Results 151 to 160 of about 1,471,936 (197)

Carbapenems versus β-lactam and β-lactamase inhibitors for treatment of nosocomial pneumonia: A systematic review and meta-analysis. [PDF]

Heliyon, 2023
Cang HQ, Quan XH, Chu XH, Liang Y, Yang X, Li J.   +5 more
europepmc   +1 more source

Synthesis and biological evaluation of novel β-lactam-metallo β-lactamase inhibitors. [PDF]

RSC Adv, 2023
Shungube M, Hlophe AK, Girdhari L, Sabe VT, Peters BB, Reddy N, Omolabi KF, Chetty L, Arumugam T, Chuturgoon A, Kruger HG, Arvidsson PI, Qin HL, Naicker T, Govender T.   +14 more
europepmc   +1 more source

Restoring ceftolozane susceptibility: a role for diazabicyclooctane β-lactamase inhibitors? [PDF]

Antimicrob Agents Chemother
Dorazio AJ, Kline EG, Squires KM, Pogue JM, Van Tyne D, Shields RK.   +5 more
europepmc   +1 more source

Will the introduction of β-lactamase inhibitors alter the adverse event profile of parent penicillins antibiotics? a pharmacovigilance study based on amoxicillin-clavulanate and ampicillin-sulbactam. [PDF]

Front Pharmacol
He Y, Liao Y, Xiao G, Zhou D, Huang L, Wei S.   +5 more
europepmc   +1 more source

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study. [PDF]

Antimicrob Agents Chemother
Gottesdiener LS, Li Y, Greenwood-Quaintance KE, Komarow L, Arias CA, Cober E, Herc ES, Kaye KS, Huskins WC, Figueroa J, Vilchez S, Fries BC, Leroi M, McCarty TP, Rioseco ML, Munita JM, Stryjewski ME, Reyes J, Chen L, Kreiswirth BN, Hill C, Baum K, Villegas MV, Paterson DL, Bonomo RA, Chambers HF, Fowler VG, Patel R, Doi Y, van Duin D, Satlin MJ, Antibacterial Resistance Leadership Group.   +31 more
europepmc   +1 more source

Harder than Metal: Challenging Antimicrobial Resistance with Metallo-β-lactamase Inhibitors. [PDF]

J Med Chem
De Falco A, Alfano AI, Cutarella L, Mori M, Brindisi M.   +4 more
europepmc   +1 more source

Challenges of Carbapenem-Resistant <i>Enterobacteriaceae</i> in the Development of New β-Lactamase Inhibitors and Antibiotics. [PDF]

Antibiotics (Basel)
Leroux P, Bornet C, Bolla JM, Cohen A.
europepmc   +1 more source

A Review of <i>β</i>-Lactamase Inhibitors in Clinical Use and Development: Mechanisms, Spectrum, and Therapeutic Applications. [PDF]

Int J Microbiol
Gourabi MJR, Nikoo A, Khanbabaei B, Kargar M, Fayyazi A, Mousavi SMJ, Aghdaee A, Hashemi A, Sharahi JY.   +8 more
europepmc   +1 more source

Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry. [PDF]

Int J Mol Sci
Santi N, Piccirilli A, Corsini F, Taracila MA, Perilli M, Bonomo RA, Fini F, Prati F, Caselli E.   +8 more
europepmc   +1 more source

Sustainable Joullié-Ugi and Continuous Flow Implementation Led to Novel Captopril-Inspired Broad-Spectrum Metallo-β-Lactamase Inhibitors. [PDF]

J Med Chem
Alfano AI, Pelliccia S, Barone S, Cutarella L, Cancade SMI, Baia V, Cassese E, Russomanno P, Messano N, Frank D, Weizel L, Rotter MJ, Brunst S, Wichelhaus TA, Proschak E, Tedesco D, Mori M, Docquier JD, Summa V, Brindisi M.   +19 more
europepmc   +1 more source